Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Giuseppe, Pinnetta"'
Autor:
Ivana Ferrero, Sara Castiglia, Aloe Adamini, Alessandra Mandese, Francesca Sismondi, Deborah Rustichelli, Marco Leone, Giuseppe Pinnetta, Lucia Giordanengo, Katia Mareschi, Franca Fagioli
Publikováno v:
Translational Medicine Communications, Vol 8, Iss 1, Pp 1-13 (2023)
Abstract Background Media fills are used to demonstrate the adequacy of the aseptic conditions of a pharmaceutical production process, according to good manufacturing practice (GMP), using a growth medium in place of the product solution. For advance
Externí odkaz:
https://doaj.org/article/ea2493760cb44bf7a61dc73f267b04ce
Autor:
Giuseppe Pinnetta, Aloe Adamini, Franco Severina, Franca Fagioli, Cristina Zanini, Ivana Ferrero
Publikováno v:
Bioengineering, Vol 10, Iss 9, p 1047 (2023)
The primary aim of this systematic analysis is to highlight opportunities to improve the environmental impact of advanced therapy medicinal products (ATMP) manufacturing. We have compared the Greenhouse Gas (GHG) emissions expressed in CO2eq of a cla
Externí odkaz:
https://doaj.org/article/97012b5ec4f14cc7a9d3d73e21968776
Autor:
Sara Castiglia, Aloe Adamini, Deborah Rustichelli, Laura Castello, Katia Mareschi, Giuseppe Pinnetta, Marco Leone, Alessandra Mandese, Ivana Ferrero, Giulia Mesiano, Franca Fagioli
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-9 (2018)
Abstract Background Cytokine-induced killer (CIK) cells are a very promising cell population raising growing interest in the field of cellular antitumor therapy. The aim of our study was to validate the most advantageous expansion method for this adv
Externí odkaz:
https://doaj.org/article/50cb26875eb548b39b9c88ffa8018694
Autor:
Katia Mareschi, Aloe Adamini, Sara Castiglia, Deborah Rustichelli, Laura Castello, Alessandra Mandese, Marco Leone, Giuseppe Pinnetta, Giulia Mesiano, Ivana Ferrero, Franca Fagioli
Publikováno v:
Pharmaceuticals, Vol 13, Iss 5, p 93 (2020)
Cytokine-induced killer (CIK) cells are advanced therapy medicinal products, so their production and freezing process has to be validated before their clinical use, to verify their stability as a drug formulation according to the good manufacturing p
Externí odkaz:
https://doaj.org/article/1cd2b7c216af419babe79916e49437ff
Autor:
Katia Mareschi, Elena Marini, Alessia Giovanna Santa Banche Niclot, Marta Barone, Giuseppe Pinnetta, Aloe Adamini, Manuela Spadea, Luciana Labanca, Graziella Lucania, Ivana Ferrero, Franca Fagioli
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 6; Pages: 3234
Mesenchymal stem cells (MSCs) are classified as advanced therapy medicinal products, a new category of GMP (good manufacturing practice)-compliant medicines for clinical use. We isolated MSCs from 5 bone marrow (BM) samples using human platelet lysat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bca2be8c30bac86c6c9ac51d5c9ad47d
http://hdl.handle.net/2318/1851399
http://hdl.handle.net/2318/1851399
Autor:
Sara Castiglia, Aloe Adamini, Deborah Rustichelli, Laura Castello, Katia Mareschi, Giuseppe Pinnetta, Marco Leone, Alessandra Mandese, Ivana Ferrero, Giulia Mesiano, Franca Fagioli
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-1 (2018)
Following publication of the original article [1], the authors reported that all of the authors’ names were processed incorrectly so that their given and family names were interchanged. In this Correction the correct author names are shown. The ori
Externí odkaz:
https://doaj.org/article/5f3f8cf9be234129a3ee1216d21d1203
Autor:
Aloe Adamini, Katia Mareschi, Giulia Mesiano, Marco Leone, Ivana Ferrero, Deborah Rustichelli, Alessandra Mandese, Sara Castiglia, Laura Castello, Giuseppe Pinnetta, Franca Fagioli
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-1 (2018)
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-1 (2018)
Cytokine-induced killer (CIK) cells are a very promising cell population raising growing interest in the field of cellular antitumor therapy. The aim of our study was to validate the most advantageous expansion method for this advanced therapy medici
Autor:
Franca Fagioli, Giulia Mesiano, Laura Castello, Ivana Ferrero, Marco Leone, Giuseppe Pinnetta, Katia Mareschi, Aloe Adamini, Deborah Rustichelli, Sara Castiglia, Alessandra Mandese
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-9 (2018)
Journal of Translational Medicine
Journal of Translational Medicine
Background Cytokine-induced killer (CIK) cells are a very promising cell population raising growing interest in the field of cellular antitumor therapy. The aim of our study was to validate the most advantageous expansion method for this advanced the